Search

everythinglearnresearchcommunity

for

Search:↓

Upadacitinib effectively treats severe alopecia areata and is safe.

Deuruxolitinib significantly helps regrow scalp hair in adults with moderate to severe alopecia areata.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Baricitinib significantly regrows hair in teens with severe alopecia areata.

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.

Ritlecitinib is effective and safe for long-term treatment of alopecia areata.

Deuruxolitinib effectively regrows hair in adults with alopecia areata and is well tolerated.

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

Guselkumab significantly improves psoriasis symptoms within 12 weeks.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Ritlecitinib is effective for long-term treatment of severe alopecia areata.

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

Bexarotene 1% topical gel helped some patients with alopecia areata regrow hair.

CTP-543 is generally safe for treating alopecia areata.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

Deuruxolitinib improves anxiety and depression in severe alopecia areata patients.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.